A comprehensive analysis of evidence-based information to help manage myopia - News-Medical.Net

A comprehensive analysis of evidence-based information to help manage myopia - News-Medical.Net

ACE inhibitors should not be discontinued over fears about COVID-19, say researchers The review also discusses potential future avenues for myopia management, including a continuum of care starting with the delay of onset followed by individual or combination therapies to slow myopia progression. "Management of an individual child should be underpinned by the evidence-based literature and clinicians must stay alert for ongoing myopia research. [This] will undoubtedly result in the evolution of the standard of care for the myopic and pre-myopic child," write Bullimore and Richdale. The review supports a call for ophthalmology and optometry to determine a collaborative framework and referral patterns in the interest of prevention, education, and proactively addressing associated pathology. This includes working with the pediatrics and school communities to reach a broad population with high impact. The paper was supported by an educational grant from CooperVision. We hope this comprehensive review reaches ECPs to offer sound, science-backed evaluation that can help advance myopia management strategies in practices worldwide,Clinical education plays an important role in our efforts to grow the category, alongside ongoing research, groundbreaking products such as our MiSight® 1 day contact lenses, advocacy and corporate social responsibility initiatives." James Gardner, Vice President, Global Myopia Management, CooperVision Source: McDougall Communications Journal reference: Bullimore.A. M. & Richdale. K., (2020) A Myopia Control 2020: Where are we and where are we heading? Ophthalmic & Physiological Optics . doi.org/10.1111/opo.12686.



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More